Читать книгу Pathy's Principles and Practice of Geriatric Medicine - Группа авторов - Страница 411

1 1. Robinson AG and Verbalis, JG. Posterior pituitary. In: Melmed S, Polonsky KS, Reed Larsen P, Kronenberg HM, ed. Williams Textbook of Endocrinolgy. Elsevier; 2016:300–332.

2 2. Dineen R, Hannon MJ, Thompson, CJ. Hyponatremia and Hypernatremia. In: Jameson JL, et al, ed. Endocrinology: Adult and Peditric. 7 ed.: Saunders; 2016:1953–1964.

3 3. Morley JE. Dehydration, hypernatremia, and hyponatremia. Clin Geriatr Med. 2015; 31(3):389–399.

4 4. Woodward M, Gonski P, Grossmann M, Obeid J, Scholes R, Topliss DJ. Diagnosis and management of hyponatraemia in the older patient. Intern Med J. 2018; 48 Suppl 1:5–12.

5 5. Miller M. Hyponatremia and arginine vasopressin dysregulation: mechanisms, clinical consequences, and management. J Am Geriatr Soc. 2006; 54(2):345–353.

6 6. McKenna K, Thompson C. Osmoregulation in clinical disorders of thirst appreciation. Clin Endocrinol (Oxf). 1998; 49(2):139–152.

7 7. Begg DP. Disturbances of thirst and fluid balance associated with aging. Physiol Behav. 2017; 178:28–34.

8 8. Verbalis JG, Goldsmith SR, Greenberg A, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med. 2013; 126(10 Suppl 1):S1–42.

9 9. Ellison DH, Berl T. Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med. 2007; 356(20):2064–2072.

10 10. Adrogue HJ, Madias NE. Hypernatremia. N Engl J Med. 2000; 342(20):1493–1499.

11 11. Cowen LE, Hodak SP, Verbalis JG. Age‐associated abnormalities of water homeostasis. Endocrinol Metab Clin North Am. 2013; 42(2):349–370.

12 12. Luckey AE, Parsa CJ. Fluid and electrolytes in the aged. Arch Surg. 2003; 138(10):1055–1060.

13 13. Phillips PA, Rolls BJ, Ledingham JG, et al. Reduced thirst after water deprivation in healthy elderly men. N Engl J Med. 1984; 311(12):753–759.

14 14. Phillips PA, Johnston CI, Gray L. Disturbed fluid and electrolyte homoeostasis following dehydration in elderly people. Age Ageing. 1993; 22(1):S26–33.

15 15. Phillips PA, Bretherton M, Risvanis J, Casley D, Johnston C, Gray L. Effects of drinking on thirst and vasopressin in dehydrated elderly men. Am J Physiol. 1993; 264(5 Pt 2):R877–881.

16 16. Tian Y, Serino R, Verbalis JG. Downregulation of renal vasopressin V2 receptor and aquaporin‐2 expression parallels age‐associated defects in urine concentration. American journal of physiology Renal physiology. 2004; 287(4):F797–805.

17 17. Albert SG, Nakra BR, Grossberg GT, Caminal ER. Vasopressin response to dehydration in Alzheimer's disease. J Am Geriatr Soc. 1989; 37(9):843–847.

18 18. Kayser‐Jones J, Schell ES, Porter C, Barbaccia JC, Shaw H. Factors contributing to dehydration in nursing homes: inadequate staffing and lack of professional supervision. J Am Geriatr Soc. 1999; 47(10):1187–1194.

19 19. Arinzon Z, Feldman J, Peisakh A, Zuta A, Berner Y. Water and sodium disturbances predict prognosis of acute disease in long term cared frail elderly. Arch Gerontol Geriatr. 2005; 40(3):317–326.

20 20. Miller M, Morley JE, Rubenstein LZ. Hyponatremia in a nursing home population. J Am Geriatr Soc. 1995; 43(12):1410–1413.

21 21. Davis PJ, Davis FB. Water excretion in the elderly. Endocrinol Metab Clin North Am. 1987; 16(4):867–875.

22 22. Crowe MJ, Forsling ML, Rolls BJ, Phillips PA, Ledingham JG, Smith RF. Altered water excretion in healthy elderly men. Age Ageing. 1987; 16(5):285–293.

23 23. Schrier RW, Gross P, Gheorghiade M, et al. Tolvaptan, a selective oral vasopressin V2‐receptor antagonist, for hyponatremia. N Engl J Med. 2006; 355(20):2099–2112.

24 24. Liamis G, Milionis H, Elisaf M. A review of drug‐induced hyponatremia. Am J Kidney Dis. 2008; 52(1):144–153.

25 25. Jacob S, Spinler SA. Hyponatremia associated with selective serotonin‐reuptake inhibitors in older adults. Ann Pharmacother. 2006; 40(9):1618–1622.

26 26. Liamis G, Filippatos TD, Elisaf MS. Thiazide‐associated hyponatremia in the elderly: what the clinician needs to know. J Geriatr Cardiol. 2016; 13(2):175–182.

27 27. Hirshberg B, Ben‐Yehuda A. The syndrome of inappropriate antidiuretic hormone secretion in the elderly. Am J Med. 1997; 103(4):270–273.

28 28. Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008; 358(18):1887–1898.

29 29. Renneboog B, Musch W, Vandemergel X, Manto MU, Decaux G. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med. 2006; 119(1):71 e71‐78.

30 30. Fehlberg EA, Lucero RJ, Weaver MT, et al. Associations between hyponatraemia, volume depletion and the risk of falls in US hospitalised patients: a case‐control study. BMJ Open. 2017; 7(8):e017045.

31 31. Rittenhouse KJ, To T, Rogers A, et al. Hyponatremia as a fall predictor in a geriatric trauma population. Injury. 2015; 46(1):119–123.

32 32. Chung MC, Yu TM, Shu KH, et al. Hyponatremia and increased risk of dementia: A population‐based retrospective cohort study. PLoS One. 2017; 12(6):e0178977.

33 33. Gankam Kengne F, Andres C, Sattar L, Melot C, Decaux G. Mild hyponatremia and risk of fracture in the ambulatory elderly. QJM. 2008; 101(7):583–588.

34 34. Usala RL, Fernandez SJ, Mete M, et al. Hyponatremia is associated with increased osteoporosis and bone fractures in a large US health system population. J Clin Endocrinol Metab. 2015; 100(8):3021–3031.

35 35. Murthy K, Ondrey GJ, Malkani N, et al. The effects of hyponatremia on bone density and fractures: a systematic review and meta‐analysis. Endocr Pract. 2019; 25(4):366–378.

36 36. Corona G, Norello D, Parenti G, Sforza A, Maggi M, Peri A. Hyponatremia, falls and bone fractures: A systematic review and meta‐analysis. Clin Endocrinol (Oxf). 2018; 89(4):505–513.

37 37. Upala S, Sanguankeo A. Association between hyponatremia, osteoporosis, and fracture: a systematic review and meta‐analysis. J Clin Endocrinol Metab. 2016; 101(4):1880–1886.

38 38. Verbalis JG, Barsony J, Sugimura Y, et al. Hyponatremia‐induced osteoporosis. J Bone Miner Res. 2010; 25(3):554–563.

39 39. Abraham WT, Decaux G, Josiassen RC, et al. Oral lixivaptan effectively increases serum sodium concentrations in outpatients with euvolemic hyponatremia. Kidney Int. 2012; 82(11):1215–1222.

40 40. Verbalis JG, Ellison H, Hobart M, Krasa H, Ouyang J, Czerwiec FS. Tolvaptan and neurocognitive function in mild to moderate chronic hyponatremia: a randomized trial (INSIGHT). Am J Kidney Dis. 2016; 67(6):893–901.

41 41. Bhandari S, Peri A, Cranston I, et al. A systematic review of known interventions for the treatment of chronic nonhypovolaemic hypotonic hyponatraemia and a meta‐analysis of the vaptans. Clin Endocrinol (Oxf). 2017; 86(6):761–771.

42 42. Hannon MJ, Behan LA, O'Brien MM, et al. Hyponatremia following mild/moderate subarachnoid hemorrhage is due to SIAD and glucocorticoid deficiency and not cerebral salt wasting. J Clin Endocrinol Metab. 2014; 99(1):291–298.

43 43. Fenske W, Stork S, Blechschmidt A, Maier SG, Morgenthaler NG, Allolio B. Copeptin in the differential diagnosis of hyponatremia. J Clin Endocrinol Metab. 2009; 94(1):123–129.

44 44. Koenig MA, Bryan M, Lewin JL, 3rd, Mirski MA, Geocadin RG, Stevens RD. Reversal of transtentorial herniation with hypertonic saline. Neurology. 2008; 70(13):1023–1029.

45 45. Garrahy A, Dineen R, Hannon AM, et al. Continuous versus bolus infusion of hypertonic saline in the treatment of symptomatic hyponatremia due to SIAD. J Clin Endocrinol Metab. 2019.

46 46. Peri A. Clinical review: the use of vaptans in clinical endocrinology. J Clin Endocrinol Metab. 2013; 98(4):1321–1332.

47 47. Gheorghiade M, Konstam MA, Burnett JC, Jr., et al. Short‐term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. Jama. 2007; 297(12):1332–1343.

48 48. Dasta JF, Sundar S, Chase S, Lingohr‐Smith M, Lin J. Economic impact of tolvaptan treatment vs. fluid restriction based on real‐world data among hospitalized patients with heart failure and hyponatremia. Hospital practice (1995). 2018; 46(4):197–202.

49 49. Liber M, Sonnenblick M, Munter G. Hypernatremia and copeptin levels in the elderly hospitalized patient. Endocr Pract. 2016; 22(12):1429–1435.

50 50. Nigro N, Winzeler B, Suter‐Widmer I, et al. Copeptin levels and commonly used laboratory parameters in hospitalised patients with severe hypernatraemia – the ‘Co‐MED study’. Crit Care. 2018; 22(1):33.

51 51. Davies I, O'Neill PA, McLean KA, Catania J, Bennett D. Age‐associated alterations in thirst and arginine vasopressin in response to a water or sodium load. Age Ageing. 1995; 24(2):151–159.